Further, targeting MALAT1 was shown to change PCa cell metabolism towards a more glycolytic phenotype and to decrease the expression of oxidative phosphorylation enzymes causing cell arrest and death by Nanni et al. [51]. The gene discussed is MALAT1; the disease is posterior cortical atrophy.